# SCIENTURE HOLDINGS, INC. (SCNX) · Edgar & Edgarette company card

> Scienture Holdings (SCNX) grew revenue 216% in FY2025 to $0 million, operating margin -9868% against a -3.8% median for pharmaceutical preparations, equity 83.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1382574 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SCNX) · [JSON](https://www.pops4.com/boards/company/SCNX.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $431,609 |
| Revenue growth, 1 year | 215.9% |
| Revenue growth per year | -54.3% |
| Operating margin | -9867.9% (prior year -10758.7%) |
| Net margin | -9618.0% |
| Operating cash flow | −$13M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $7M |
| Long-term debt | — |
| Total assets | $84M |
| Total equity | $70M |
| Equity ÷ assets | 83.3% |
| Return on equity | -59.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -0.88 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$13.4M in FY2025); operating loss: a margin of -9867.9% in FY2025; revenue is hard to predict: its 80% range is ±81%

## Edgarette's reading

Exposure: revenue $432K (FY2025). Experience: revenue up 215.9% on the year, down 54.3% a year over 4 years; operating margin -9867.9%, up from -10758.7%. Soundness: equity 83.3% of assets, return on equity -59.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $239K and $2.3M next year (method v4.1: its own 4-year record of growth weighed at 50% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $205K to $2.8M. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -9867.9% against a -3.8% median; growth 215.9% against 13.7%.

Range logged 2026-09-24, receipt 601615e063aff354, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-10-19 ([filing](https://www.sec.gov/Archives/edgar/data/1382574/000149315226047579/0001493152-26-047579-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-05-29 ([filing](https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/0001493152-26-026414-index.htm))

## Recent filings

- 8-K · filed 2026-11-03 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1382574/000149315226049787/0001493152-26-049787-index.htm)
- 8-K · filed 2026-10-19 · 2.02 Results of Operations and Financial Condition; 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1382574/000149315226047579/0001493152-26-047579-index.htm)
- 8-K · filed 2026-10-07 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1382574/000149315226046176/0001493152-26-046176-index.htm)
- DEF 14A · filed 2026-09-18 · [filing](https://www.sec.gov/Archives/edgar/data/1382574/000149315226043340/0001493152-26-043340-index.htm)
- 8-K · filed 2026-09-14 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1382574/000149315226042575/0001493152-26-042575-index.htm)
- 8-K · filed 2026-08-20 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1382574/000149315226039474/0001493152-26-039474-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001382574.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1382574

## Cite

POPS4, Edgar & Edgarette: SCIENTURE HOLDINGS, INC. (SCNX) company card, from the company's own SEC filings, accessed 2026-11-06, https://www.pops4.com/boards/company/SCNX. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.